|
11 |
Major response and clinical benefit following third-line treatment for Bellini duct carcinoma Enthalten in Wiener klinische Wochenschrift Bd. 117, 1.1.2005, Nr. 1-2, date:1.2005: 63-65
|
|
|
12 |
Phase II study on the efficacy and safety of Lapatinib administered beyond disease progression and combined with vinorelbine in HER-2/neu– positive advanced breast cancer: results of the CECOG LaVie trial Enthalten in BMC cancer Bd. 16, 18.2.2016, Nr. 1, date:12.2016: 1-7
|
|
|
13 |
SPAG6 and L1TD1 are transcriptionally regulated by DNA methylation in non-small cell lung cancers Enthalten in Molecular cancer Bd. 16, 5.1.2017, Nr. 1, date:12.2017: 1-12
|
|
|
14 |
The circulating form of neprilysin is not a general biomarker for overall survival in treatment-naïve cancer patients Enthalten in Scientific reports Bd. 9, 22.2.2019, Nr. 1, date:12.2019: 1-8
|
|